| Patient relevant outcomes for type 1 diabetes management : A qualitative evidence synthesis | Diabetic medicine |  | | 2025 | 40 | 0 |
|
| The Lancet Diabetes & Endocrinology Commission on type 1 diabetes : looking back to move forward | The Lancet. Diabetes & endocrinology | | | 2024 | 49 | 0 |
|
| Using a co-creation approach to develop a Core Outcome Set for Type 1 Diabetes Mellitus | |  | | 2024 | 232 | 220 |
|
| Involving different stakeholders in prioritising outcomes to assess healthcare systems response for type 1 diabetes management : Using co-creation approaches in Peru | The International journal of health planning and management | | | 2024 | 48 | 260 |
|
| Outcomes measured in studies assessing health systems interventions for type 1 diabetes management : A scoping review | Diabetic medicine | | | 2024 | 61 | 152 |
|
| Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru | Journal of pharmaceutical policy and practice | | | 2022 | 101 | 199 |
|
| Management of type 1 diabetes in low‐ and middle‐income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania | Diabetic medicine | | | 2022 | 236 | 261 |
|
| COVID‐19's impact on type 1 diabetes management : A mixed‐methods study exploring the Peruvian experience | The International journal of health planning and management | | | 2022 | 48 | 285 |
|
| Diabetes and the WHO Model List of Essential Medicines | The Lancet. Diabetes & endocrinology | | | 2022 | 176 | 0 |
|
| Health system responses for type 1 diabetes: A scoping review | Diabetic medicine | | | 2022 | 232 | 626 |
|
